T
Tobias Gerhard
Researcher at Rutgers University
Publications - 93
Citations - 4538
Tobias Gerhard is an academic researcher from Rutgers University. The author has contributed to research in topics: Hazard ratio & Population. The author has an hindex of 33, co-authored 81 publications receiving 3806 citations. Previous affiliations of Tobias Gerhard include University of Florida & Rutgers Biomedical and Health Sciences.
Papers
More filters
Journal ArticleDOI
Premature Mortality Among Adults With Schizophrenia in the United States
TL;DR: In a US national cohort of adults with schizophrenia, excess deaths from cardiovascular and respiratory diseases implicate modifiable cardiovascular risk factors, including especially tobacco use, which highlight threats posed by substance abuse.
Journal ArticleDOI
Broadened Use Of Atypical Antipsychotics: Safety, Effectiveness, And Policy Challenges
TL;DR: Challenges for health care systems, regulators, and policymakers include developing the evidence base on comparative risks and benefits; defining measures of treatment quality; and implementing policies that encourage evidence-based practices while avoiding unduly burdensome restrictions.
Journal ArticleDOI
Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study
Krista F. Huybrechts,Tobias Gerhard,Stephen Crystal,Mph Mark Olfson Md,Jerry Avorn,Robert Marc Levin,Judith A. Lucas,Sebastian Schneeweiss +7 more
TL;DR: The data suggest that the risk of mortality with these drugs is generally increased with higher doses and seems to be highest for haloperidol and least for quetiapine, reinforcing the concept that they should be used in the absence of clear need.
Broadened Use Of Atypical Antipsychotics: Safety, Effectiveness, And Policy
TL;DR: Atypical antipsychotic medications are increasingly used for a wide range of clinical indications in diverse populations, including privately and publicly insured youth and elderly nursing home residents as discussed by the authors, which heighten policy challenges for payers, pa- tients, and clinicians related to appropriate prescribing and management, patient safety, and clinical effectiveness.
Journal ArticleDOI
The incident user design in comparative effectiveness research.
Eric S. Johnson,Barbara A. Bartman,Becky A. Briesacher,Neil S. Fleming,Tobias Gerhard,Cynthia J. Kornegay,Parivash Nourjah,Brian C. Sauer,Glen T. Schumock,Art Sedrakyan,Til Stürmer,Suzanne L West,Sebastian Schneeweiss +12 more
TL;DR: This article takes the incident user design as a reasonable default strategy because it reduces biases that can impact non‐randomized studies, especially when investigators use healthcare databases.